latimes -- Drug Industry Poised to Reap Political Dividends

Few industries campaigned harder than pharmaceutical manufacturers to elect Republicans to the new Congress, and few industries are better positioned to reap the rewards of the election returns, analysts said Thursday.

Payback time for their $50 million investment in Republican congressman.